Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CUPRIC vs CUPRIC ANHYDROUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CUPRIC vs CUPRIC ANHYDROUS: Safety Overview

Metric CUPRIC CUPRIC ANHYDROUS
Total FAERS Reports 376 110
Deaths Reported 5 32
Death Rate 1.3% 29.1%
Hospitalizations 127 58
Average Patient Age 68.2 yrs 57.2 yrs
% Female Patients 96.4% 23.2%
FDA Approval Date Apr 30, 2024 N/A
Manufacturer American Regent, Inc. Hahnemann Laboratories, INC.
Route INTRAVENOUS ORAL
Marketing Status Prescription N/A